Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,134,238
  • Shares Outstanding, K 126,041
  • Annual Sales, $ 739,020 K
  • Annual Income, $ -436,370 K
  • EBIT $ -442 M
  • EBITDA $ -404 M
  • 60-Month Beta 1.58
  • Price/Sales 15.42
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 59.41% (-0.06%)
  • Historical Volatility 41.21%
  • IV Percentile 34%
  • IV Rank 21.30%
  • IV High 103.43% on 04/04/25
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 32) 13.60 (12.13%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 2,051
  • Volume Avg (30-Day) 1,188
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 46,395
  • Open Int (30-Day) 44,214
  • Expected Range 98.54 to 125.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.81
  • Number of Estimates 4
  • High Estimate -0.76
  • Low Estimate -0.86
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.28 +16.47%
on 12/18/25
115.54 -2.94%
on 01/16/26
+12.14 (+12.14%)
since 12/16/25
3-Month
64.00 +75.22%
on 10/17/25
115.54 -2.94%
on 01/16/26
+44.67 (+66.21%)
since 10/16/25
52-Week
34.88 +221.50%
on 03/10/25
115.54 -2.94%
on 01/16/26
+74.83 (+200.56%)
since 01/16/25

Most Recent Stories

More News
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group

Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group

GH : 112.14 (+0.14%)
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results

Fourth quarter revenue growth of 39% driven by strong Oncology and Screening volume

GH : 112.14 (+0.14%)
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

Active-duty service members and eligible family members now have access to blood test for colorectal cancer screening with no copay

GH : 112.14 (+0.14%)
1 Growth Stock Set to Flourishand 2 We Avoid

1 Growth Stock Set to Flourishand 2 We Avoid

GH : 112.14 (+0.14%)
CDNS : 317.45 (-0.98%)
WD : 65.35 (-0.88%)
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44 th Annual J.P. Morgan Healthcare Conference in San...

GH : 112.14 (+0.14%)
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Partnership integrates Guardant’s large-scale genomic data with Trial Library’s AI-powered matching and navigation platform to expand equitable access to oncology clinical trials across the United...

GH : 112.14 (+0.14%)
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Leading European Hospital System Begins Offering On-site Liquid Biopsy Testing Based on Proprietary Guardant360® CDx Technology

GH : 112.14 (+0.14%)
3 Volatile Stocks Walking a Fine Line

3 Volatile Stocks Walking a Fine Line

GH : 112.14 (+0.14%)
NMRK : 17.44 (-0.46%)
FND : 76.07 (+0.73%)
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

Presentations highlight advancements in cancer recurrence detection with Guardant Reveal and real-time treatment response monitoring with Guardant360 Liquid

GH : 112.14 (+0.14%)
Why Guardant Health (GH) Stock Is Up Today

Why Guardant Health (GH) Stock Is Up Today

GH : 112.14 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 120.54
2nd Resistance Point 118.04
1st Resistance Point 115.09
Last Price 112.14
1st Support Level 109.64
2nd Support Level 107.14
3rd Support Level 104.19

See More

52-Week High 115.54
Last Price 112.14
Fibonacci 61.8% 84.73
Fibonacci 50% 75.21
Fibonacci 38.2% 65.69
52-Week Low 34.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar